Navigation Links
Know your drugs: A primer for chemical and life science professionals is ACS Webinars topic
Date:3/22/2011

WASHINGTON, March 21, 2011 The modern drug discovery process is the topic of the next in a series of American Chemical Society (ACS) Webinars for scientists and chemical professionals.

Scheduled for Thursday, March 24, from 2 3 p.m., EDT, the free webinar features Terry Kenakin, a Director of Platform Technology Sciences at GlaxoSmithKline Research and Development in Research Triangle Park, North Carolina.

Participants will learn:

  • Stages of the modern drug discovery process
  • How pharmacokinetics and pharmacodynamics are used to guide discovery
  • The primary assays used in discovery and development to guide optimization of efficacy and PK properties, what these assays give you, and how to interpret the data

Kenakin earned his B.S. in chemistry and Ph.D. in pharmacology at the University of Alberta, Canada. After three years at University College, London, UK, he joined Burroughs-Wellcome as a senior research pharmacologist. He then joined GlaxoSmithKline. Kenakin is the author of eight books on pharmacology including most recently, A Pharmacology Primer, Third Edition: Theory, Application and Methods. He is co-editor-in-chief of the International Journal of Receptors and Signal Transduction and Current Opinion in Pharmacology.


'/>"/>

Contact: Nancy McCormick-Pickett
n_mccormick-pickett@acs.org
202-872-4381
American Chemical Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Too Few Get Needed Rheumatoid Arthritis Drugs: Study
2. Heart Risks the Same With 2 Diabetes Drugs: Study
3. A primer on aspirating breast lumps
4. Plastics Chemical Affects U.S. More Than Canada: Study
5. Latest American Chemical Society podcast: Dont blame the pill for estrogen in drinking water
6. Worlds first chemical guided missile could be the answer to wiping out cancer
7. Study Links MS to Brain Chemical Deficiency
8. Naturally occurring brain signaling chemical may be useful in understanding Parkinsons
9. American Chemical Society unveils International Year of Chemistry virtual journal
10. Fat associated with chemical changes in DNA that may help explain obesity-related disease
11. Ovarian Cyst Syndrome May Raise Health Risks from Plastics Chemical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Seattle, WA, and Washington, DC (PRWEB) , ... ... ... PATH and the Siemens Foundation today announced a new initiative—the Siemens ... technologies for low-resource settings. The partnership will recruit top students from U.S. ...
(Date:2/12/2016)... ... 12, 2016 , ... Each year, the American Physical Therapy Association (APTA) offers ... the Anaheim Convention Center. Almost 10,000 physical therapists across the country are expected to ... more about their chosen field and network with their colleagues. As in years ...
(Date:2/12/2016)... Appleton, Wis. (PRWEB) , ... February 12, 2016 ... ... its second Lean Leadership Series at Zuckerberg San Francisco General Hospital on April ... to practice new behaviors and create new habits. The workshops cover a broad ...
(Date:2/12/2016)... Washington, NC (PRWEB) , ... February 12, 2016 , ... ... the surrounding areas, is initiating a charity drive that will raise funds earmarked to ... at John C. Tayloe Elementary School. , “My school is in a low-income area ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... of the Pittsburgh metro area, celebrates the beginning of the latest charity campaign ... develop social skills through art. Donations to this worthy cause are currently being ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... 12, 2016  Aralez Pharmaceuticals Inc. (Nasdaq: ARLZ ... Company will ring the Nasdaq Closing Bell at the ... at 4:00 p.m. ET on Tuesday, February ... Adrian Adams , will perform the honorary ... 4:00 p.m. ET.  A live webcast will be available ...
(Date:2/12/2016)... , Feb. 12, 2016  Apellis Pharmaceuticals, ... a $47.1 million Series D preferred stock ... Management, Hillhouse Capital Group and venBio Global ... Investments, AJU IB Investment, and Epidarex Capital. The ... to further advance clinical trials in the ...
(Date:2/11/2016)... 2016 - Cardiac Marker ... Medicine and Cancer Therapy. - European Point of ... Markets. - Key Diagnostic Testing Markets. - ... in Genetic Testing. - Molecular Diagnostics in Infectious ... Over-the-Counter Diagnostic Products World Markets. - Point of ...
Breaking Medicine Technology: